Health
EU’s Health Package is Europe’s answer to Trump’s drug pricing policy, says Várhelyi
Várhelyi estimated reforms could lower business costs by 20-25 percent - potentially offsetting the impact of US tariffs and "MFN" pricing.
Asked about the impact of Trump’s so-called ‘most-favoured nation’ pricing, European Health Commissioner Olivér Várhelyi said that Europe’s strategy goes beyond pricing disputes and instead focuses on strengthening innovation, investment, and healthcare access across the EU.
Speaking after the Informal Health Council in Nicosia, Várhelyi stressed that the issue cannot be reduced solely to drug prices or tariffs and that recent regulatory decisions could reduce costs.
“My personal educated guess is that we are achieving between 20 and 25 percent cost reductions,” he said, suggesting that these savings could outweigh the impact of potential tariffs of around 15 percent.
The Commissioner said...

Share this article:
EU Reporter publishes articles from a variety of outside sources which express a wide range of viewpoints. The positions taken in these articles are not necessarily those of EU Reporter. Please see EU Reporter’s full Terms and Conditions of publication for more information EU Reporter embraces artificial intelligence as a tool to enhance journalistic quality, efficiency, and accessibility, while maintaining strict human editorial oversight, ethical standards, and transparency in all AI-assisted content. Please see EU Reporter’s full A.I. Policy for more information.
-
Health4 days agoCounterfeit cigarettes drive illicit tobacco trade to highest level in a decade, new study claims
-
Libya4 days agoLibya’s fuel crisis offers lessons for energy security on both sides of the Mediterranean
-
Law4 days agoEU Cybersecurity Act could expose member states to costly investment treaty claims, legal opinion warns
-
Space4 days agoIn space, we can’t defend what we can’t see
